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Abstract
Background: Secondary cultures of human fibroblasts display a finite lifespan ending at
senescence. Loss of p53 function by mutation or viral oncogene expression bypasses senescence,
allowing cell division to continue for an additional 10 – 20 doublings. During this time chromosomal
aberrations seen in mitotic cells increase while DNA damage and decatenation checkpoint
functions in G2 cells decrease.
Methods: To explore this complex interplay between chromosomal instability and checkpoint
dysfunction, human fibroblast lines were derived that expressed HPV16E6 oncoprotein or
dominant-negative alleles of p53 (A143V and H179Q) with or without the catalytic subunit of
telomerase.
Results: Cells with normal p53 function displayed 86 – 93% G1 arrest after exposure to 1.5 Gy
ionizing radiation (IR). Expression of HPV16E6 or p53-H179Q severely attenuated G1 checkpoint
function (3 – 20% arrest) while p53-A143V expression induced intermediate attenuation (55 – 57%
arrest) irrespective of telomerase expression. All cell lines, regardless of telomerase expression or
p53 status, exhibited a normal DNA damage G2 checkpoint response following exposure to 1.5 Gy
IR prior to the senescence checkpoint. As telomerase-negative cells bypassed senescence, the
frequencies of chromosomal aberrations increased generally congruent with attenuation of G2
checkpoint function. Telomerase expression allowed cells with defective p53 function to grow
>175 doublings without chromosomal aberrations or attenuation of G2 checkpoint function.
Conclusion: Thus, chromosomal instability in cells with defective p53 function appears to depend
upon telomere erosion not loss of the DNA damage induced G1 checkpoint.
Background
Normal diploid fibroblasts proliferate in secondary cul-
tures for a finite number of population doublings until a
growth arrest known as replicative senescence, or M1, is
reached [1]. This limitation in lifespan is believed to be
due to the continuous shortening of the telomeres with
each cell division [2]. Recent evidence has suggested that
an alteration in the structure of one or more telomeres
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senescence, a permanent p53-dependent G1 arrest [3,4].
Regardless of the exact trigger of senescence, inactivation
of p53 allows cells to bypass senescence and continue to
divide until a second growth restriction termed crisis, or
M2, is reached [5]. Cells in crisis contain numerous struc-
tural and numerical chromosomal abnormalities which
may be due to cycles of chromosome fusion (dicentric
chromosomes) and subsequent resolution of the fusion
(chromosome break) during mitosis [2]. A previous study
has demonstrated that during the phase of extended pro-
liferation after bypass of M1, telomeres in p53-defective,
telomerase-negative cells can erode to the point where lit-
tle or no telomeric repeat DNA can be detected [6]. Chro-
mosomes without telomeres appear to be substrates for
DNA repair pathways resulting in telomere associations
and formation of dicentric and ring chromosomes. The
resolution of these unstable structures is believed to result
in the other structural and numerical abnormalities in
chromosomes observed in cells in crisis (i.e., breaks,
exchanges, aneuploidy, polyploidy).
Prevention of telomere erosion by ectopic expression of
the catalytic subunit of human telomerase (hTERT) has
been shown to prevent crisis in cells expressing SV40 large
T antigen or HPV16E6 oncoprotein [7-10]. Normal dip-
loid human fibroblasts expressing hTERT have been
reported to maintain a normal karyotype and preserve cell
cycle checkpoint function for at least 200 population dou-
blings [11,12], although others have suggested that other-
wise normal telomerase-expressing human fibroblasts do
display alterations in expression of tumor suppressor
genes, growth characteristics, and transient genetic insta-
bility [13-16] These studies have failed to directly address
the question as to whether cells can maintain a stable
genome in the absence of a functional DNA damage
induced G1 checkpoint. Here we report that in the absence
of telomere erosion cells defective for p53 signaling can
maintain stable genomes for >175 population doublings.
This study found that normal diploid cells expressing
hTERT maintain a normal karyotype for at least 100 PD's
but eventually did become numerically abnormal. We
also report that two independent p53-defective lines
which emerged from crisis by reactivation of telomerase
displayed remarkably stable karyotypes.
Materials and methods
Plasmids and viruses
All cloning steps were carried out according to standard
methods [17]. Plasmids were maintained in the DH5α
strain of E. coli. Replication-defective retroviruses used in
this study and helper plasmids for packaging are shown in
Figure 8. The hTERT retroviral expression vector, pDSWK-
8, was created by cloning the hTERT cDNA from pBABE/
Hyg-hTERT (Dr. Robert A. Weinberg, Whitehead Institute
for Biomedical Research) into the EcoRI and HpaI sites of
the pHIT-2 retroviral backbone (Dr. John Olsen, Univer-
sity of North Carolina). cDNA's encoding an alanine to
valine substitution at amino acid 143 or a histidine to
glutamine substitution at amino acid 179 in p53 (p53-
A143V and p53-H179Q respectively) were provided by
Drs. David Wynford-Thomas (University of Aberdeen)
and Dr. Howard Liber (Massachusetts General Hospital),
respectively. Retroviral expression vectors containing
these dominant-negative forms of p53 were constructed
by cloning the cDNA into the EcoRI site of the pLXIN
(Clonetech) retroviral expression vector. The pLXSN-E6
retroviral expression vector containing the HPV16 E6
oncoprotein DNA was a gift from Dr. Denise Galloway
(Fred Hutchinson Cancer Center). Vesicular stomatitis
virus glycoprotein G-pseudotyped, replication-defective
retroviruses were produced as previously described fol-
lowing transient transfection of viral vector and helper
plasmids into HEK 293T cells [18-20]. Transfections of
plasmids for virus production were done using Superfect™
or Polyfect™ (Qiagen) according to the manufacturer's
protocol.
Cell Culture
A normal human fibroblast strain designated NHF1 was
derived from neonatal foreskin as previously described
[21]. All cell culture, including retroviral production, was
performed in a humidified, water-jacketed incubator at
37°C with a 5 % CO2 atmosphere. NHF1 cells and all cell
lines derived from the parental NHF1 secondary culture
were maintained in MEM (Gibco Invitrogen Corp.) sup-
plemented with 10 % defined fetal bovine serum
(Hyclone), 2 mM L-glutamine (Gibco Invitrogen Corp.),
and 100 µM non-essential amino acids (Gibco Invitrogen
Corp.). HEK 293T cells were maintained in DMEM-H
(Gibco Invitrogen Corp.) supplemented with 10 %
defined fetal bovine serum (Hyclone), 2 mM L-glutamine
(Gibco Invitrogen Corp.), 100 µM non-essential amino
acids (Gibco Invitrogen Corp.), and 20 mM HEPES pH
Table 1: Status of p53 in Cell Lines
Cell Line hTERT p53 Protein
F1-hTERT+LXIN + WT1
F1-hTERT+p53-A143V + WT/DN2
F1-hTERT+p53-H179Q + WT/DN
F1-hTERT+E6 + -
F1-HIT+LXIN - WT
F1-HIT+p53-A143V - WT/DN
F1-HIT+p53-H179Q - WT/DN
F1-HIT+E6 - -
1. WT: Wild Type
2. DN: Dominant NegativePage 2 of 16
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according to standard methods as described previously
[22]. Cells at passages 5 or 6 were simultaneously trans-
duced with both the hTERT-expressing virus and one of
the viruses disrupting p53 function and/or empty vectors
to derive the cell lines listed in Table 1. At the time of
transduction, the NHF1 cells were estimated to have
undergone 15 – 20 population doublings in vitro. Trans-
ductants were selected by 2 weeks growth in media con-
taining 300 ng/ml puromycin (Sigma Chemical Co.) plus
200 µg/ml of active G418 (Gibco Invitrogen Corp.) and,
following this initial selection, lines were maintained
without antibiotics. Cells were seeded each passage at a
density of 5300 – 5500 cells per cm2. The population dou-
bling level (PDL) of the culture was defined as the sum of
the population doublings (PD) of each passage. The PD of
each passage was determined using the following
equation:
Cell lines were monitored for mycoplasma contamination
using the Gen-Probe kit (Gen Probe Inc. San Diego CA)
according the manufacturer's instructions. By this method
the cell lines remained free of mycoplasma for the dura-
tion of the study.
Cell Cycle Checkpoint Analysis
DNA damage checkpoint responses were assessed follow-
ing exposure to 1.5 Gy of IR from a 137Cs source (Gamma-
Cell 40, MDS Nordion, Canada) at a dose-rate of 86 rads
per minute. G1 checkpoint function was assessed by meas-
uring 5-bromo-2'-deoxy-uridine (BrdU, Sigma Chemical
Co.) incorporation from six to eight hours following
exposure to 1.5 Gy as previously described [23-25]. Flow
cytometric and microscopic determination of mitotic
indices were shown to yield equivalent results [26,27].
DNA damage G2 checkpoint function was assessed by
determining the mitotic index of cultures two hours
following irradiation. Mitotic index was determined using
flow cytometry to measure the number of cells expressing
the phospho-histone H3 mitotic epitope or by directly
counting Giemsa- or DAPI-stained mitotic figures as pre-
viously described [28-30] Spindle damage checkpoint
function was assessed by seeding cells into medium con-
taining 100 ng/ml colcemid (Sigma Chemical Co.) for 24
or 48 hours. The cells were labeled with BrdU during the
last two hours of this incubation. Cells were then analyzed
by flow cytometry as described above to determine the
percentage of cells with >4n DNA content.
Chromosomal Analyses
Metaphase spreads were prepared from the 8 cell lines
listed in Table 1 at the earliest possible PDL following
selection and then every 10 – 20 PD thereafter until tel-
omerase-negative cells reached crisis. All metaphase prep-
arations were done according to previously described
methods [6]. Fifty metaphases from each cell line at each
PDL were analyzed and scored for number of chromo-
somes, and the numbers and types of structural abnor-
malities. G-banding was done according to standard
protocols [31] and representative karyotypes were assem-
bled after analysis of 20 to 25 metaphases.
PD
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Assessment of telomerase activity in cell lines transduced with DSWK-8 by TRAP assayFigure 1
Assessment of telomerase activity in cell lines transduced 
with DSWK-8 by TRAP assay. Each of these cell lines exhibits 
an RNase-sensitive PCR product.
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Logarithmically growing cells were seeded at 5 × 105 per
100-mm dish and incubated for 48 hr. Cultures were irra-
diated as described above and incubated for 6 hr at 37°C.
Cells were harvested by trypsinization, washed once in
PBS, and resuspended in lysis buffer (100 mM sodium
phosphate buffer, pH 7.2, 10 mM EDTA, 10 mM EGTA,
1.5 M NaCl, 10% NP40, supplemented with 10 mM 4-(2-
aminoethyl) benzenesulfonyl fluoride (AEBSF, Sigma
Chemical Co.), 10 mM β-glycerophosphate (Sigma
Chemical Co.), 10 mM sodium orthovanadate (Sigma
Chemical Co.), and 10 ug/ml of leupeptin (Sigma Chem-
ical Co.) and aprotinin Sigma Chemical Co.). Protein con-
centrations were determined using the Bio-Rad DC Protein
Assay (Bio-Rad Laboratories) according to the manufac-
turer's protocol. Samples containing 100 µg protein were
mixed with an equal volume of 2 × Laemmli sample
buffer (125 mM Tris-HCl, pH 6.8, 4% SDS, 20% glycerol)
containing 5% β-mercaptoethanol (Sigma Chemical Co.),
boiled, and separated by SDS-PAGE. Proteins were trans-
ferred to nitrocellulose and probed with antibody against
p21Waf1(Neomarkers) and detected with goat anti-rabbit
HRP using the ECL substrate (both Amersham Pharmacia
Biotech).
Results
Validation of Cell Lines
This study utilized eight isogenic cell lines differing only
in expression of telomerase and p53 function as listed in
Table 1. Following selection the cells transduced with
DSWK-8 (F1-hTERT lines) were assayed for telomerase
expression by TRAP assay [32-34]. As shown in Figure 1,
all cell lines transduced with DSWK-8 were telomerase-
positive. Cell lines transduced with the empty telomerase
vector (HIT) were telomerase-negative (data not shown).
Western immunoblot analysis confirmed there was signif-
icant overexpression of p53 in lines expressing the p53-
V143A and p53-H179Q alleles, and no detectable p53 in
lines expressing HPV16E6 (not shown).
The ability of the cells to delay entry into S-phase follow-
ing exposure to 1.5 Gy of ionizing radiation (IR) was
assessed as a quantitative index of p53-dependent G1
checkpoint function (Figure 2). The F1-HIT+LXIN and F1-
hTERT+LXIN cell lines that have an intact p53 signaling
pathway displayed an effective G1 checkpoint response to
DNA damage. In this line the percent of cells in the first
half of S phase 6 – 8 h after irradiation was reduced by
>75% due to a G1 arrest. Cells transduced with HPV16E6
and p53-H179Q exhibited severely attenuated G1 check-
point function. Less than 15% of HPV16E6-expressing
cells were delayed in G1 while cells expressing p53-H179Q
had <25% arrested in G1 post-irradiation. Cell lines
expressing the p53-A143V dominant-negative form of
p53 retained approximately half of the normal G1 check-
point response with about 50% of irradiated cells delayed
in G1. Expression of telomerase had no effect on the radi-
ation-induced G1 arrest.
Immunoblot analysis of p21Waf1 expression confirmed the
biological analysis of the G1 checkpoint (Figure 3). Cell
lines transduced with the empty LXIN vector expressed
p21Waf1 in sham-treated controls and expression was
induced after treatment with IR. Lines expressing
HPV16E6 and p53-H179Q, which displayed severe atten-
uation of G1 checkpoint function, did not express p21Waf1
in sham-treated controls nor after irradiation. Lines
expressing p53-A143V did not display full ablation of
expression or induction of p21Waf1 as evident by the low
level of expression in sham-treated controls and some
induction of protein after irradiation. As was the case for
radiation-induced G1 arrest, expression of telomerase did
not affect the expression or induction of p21Waf1. Expres-
sion of HPV16E6 and p53-H179Q ablated expression of
p21Waf1 and induced a severe attenuation of G1 check-
point function, while expression of p53-A143V attenu-
ated expression of p21Waf1 while reducing G1 checkpoint
function by about 50%. Thus the p53-A143V lines dis-
played only a partial loss of p53 function.
In contrast to their differing responses in the DNA damage
G1 checkpoint the non-telomerized F1-HIT+p53-A143V
line behaved like the non-telomerized F1-HIT+HPV16E6
and F1-HIT+p53-H179Q lines and bypassed the replica-
tive senescence checkpoint during in vitro aging. Cell pop-
ulation expansion was monitored continuously and all of
the telomerase-negative lines initially displayed equiva-
lent growth in vitro (Figure 4A). Cells expressing HPV16E6
or the dominant-negative alleles of p53 continued to
grow for 15 – 20 population doublings beyond the 60
PDL at which F1-HIT+LXIN senesced and arrested growth
(Figure 4A). After PDL 78 cell death exceeded cell birth in
the telomerase-negative, E6-expressing culture, and the
culture died by what is classically known as telomere crisis
[35]. Although population doublings did not increase
beyond PDL 80 – 85 in the p53-A143V and p53-H179Q
lines for a period of about 18 weeks and the cells appeared
to be in crisis, viable cells nevertheless remained on
dishes. After 36 weeks in culture, population expansion
resumed and two immortal lines were recovered. The
behavior of the cell lines was similar to that detailed pre-
viously [25] with p53-effective, telomerase-negative
fibroblasts undergoing replicative senescence after 60
population doublings, and the p53-defective, telomerase-
negative lines bypassing senescence and then undergoing
telomere crisis.
Population expansion in the lines transduced directly
with hTERT was continuous and equivalent to that seen in
telomerase-negative lines at PDL 40 – 60 and in the spon-Page 4 of 16
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The hTERT-expressing lines were carried to PDL >175
without reduction in growth rate. P53-dependent G1
checkpoint function was monitored during the various
phases of cellular aging in vitro and found not to vary
substantially (Table 2). Additionally the spontaneously
immortalized cell line expressing the p53-A143V domi-
nant negative p53 allele was still able to induce a small
amount of p21Waf1 following exposure to 1.5 Gy (Figure
5)
A previous report indicated that some dominant-negative
p53 alleles induced a gain of function [36]. This gain of
function was identified using a "spindle damage" assay
G1 checkpoint analysis of cell linesFigure 2
G1 checkpoint analysis of cell lines. Cells at population doubling level 25 – 30 were tested for G1 checkpoint function. Incorpo-
ration of BrdU was analyzed 6 – 8 hours after exposure to 1.5 Gy. The radiation-induced reduction in the percentage of cells 
in the first half of S-phase was determined as a quantitative measure of G1 checkpoint function.
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when incubated with microtubule poisons such as col-
cemid. This phenomenon was examined in the four-tel-
omerized cell lines derived for this study. Following 24 or
48 hours incubation in 100 ng/ml colcemid, cells were
labeled for two hours with BrdU and then analyzed by
flow cytometry to determine the rate of DNA synthesis in
diploid and tetraploid nuclei. As shown in Figure 6, all
cell lines with defective p53 signaling underwent
endoreduplication and displayed increased frequencies of
tetraploid S-phase cells when incubated in colcemid. The
isogenic F1-hTERT+LXIN line with effective p53-depend-
ent G1 checkpoint function did not display this endoredu-
plication when incubated with colcemid. Thus,
inactivation of p53 expression with HPV16E6 oncopro-
tein induced the same susceptibility to endoreduplication
during incubation in colcemid as was seen using domi-
nant-negative mutant p53 alleles to disrupt p53 signaling.
Chromosomal Instability
An assessment of chromosomal integrity was done on all
eight cell lines within five population doublings of gene
transduction to assess the background level of structural
and numerical abnormalities in the population and then
at PDL 60 (normal replicative senescence point), and PDL
75 – 85 (crisis). Table 3 demonstrates that there were no
differences among the various cell lines at the first PDL
examined. As was previously observed upon transduction
of telomerase-negative fibroblasts with HPV16E6 [6],
soon after inactivation of p53 with the dominant-negative
alleles, chromosomal number and structure appeared
normal. However, as the lines aged and approached the
normal replicative senescence point of 60 population
doublings, the number of metaphases exhibiting struc-
tural and numerical abnormalities increased dramatically
in the telomerase-negative cell lines with defective p53
function. At PDL 76 – 77, the majority of metaphases
derived from the telomerase-negative HPV16E6-, p53-
A143V-, and p53-H179Q-expressing cells exhibited
hypodiploidy and/or dicentric chromosomes. The p53-
defective lines that were transduced with hTERT to express
telomerase did not display these aging-related instabilities
in chromosome numbers and structure.
Attenuation of DNA damage G2 checkpoint function
Previous studies from this laboratory have demonstrated
that DNA damage G2 checkpoint function becomes atten-
uated in congruence with chromosomal instability
[6,25,29]. Figure 7 depicts DNA damage G2 checkpoint
function in the cell lines at various in vitro PDLs. The F1-
HIT+LXIN and F1-hTERT+LXIN lines displayed a typically
effective G2 checkpoint response with on average >95% of
G2 cells being delayed in their entry to mitosis after treat-
ment with 1.5 Gy. Expression of the dominant-negative
p53 alleles and HPV16E6 induced a modest attenuation
of G2 checkpoint function measured at PDL 30 – 40 with
7 – 24% of p53-defective cells evading radiation-induced
G2 delay. The telomerase-negative lines expressing p53-
A143V and HPV16E6 displayed further severe attenuation
of G2 checkpoint function with aging in vitro. For these
cells at PDL 70 – 80, the mitotic index in irradiated cells
was about half of that seen in sham-treated controls. The
Assessment of p53-dependent induction of p21Waf1 following IRFigure 3
Assessment of p53-dependent induction of p21Waf1 following IR. Western immuno blot to ascertain p21Waf1 induction 6 hr fol-
lowing 1.5 Gy IR was done as described in Methods.Page 6 of 16
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Journal of Carcinogenesis 2005, 4:18 http://www.carcinogenesis.com/content/4/1/18Growth curves of transduced fibroblastsFigure 4
Growth curves of transduced fibroblasts. The x-axis is the number of weeks of continuous culture. The y-axis represents the 
number of population doublings the cultures had accumulated. A. (◆) F1-HIT+LXIN; (■) F1-HIT+p53-A143V; (▲) F1-
HIT+p53-H179Q; F1-HIT+E6. The empty vector control (●) F1-HIT+LXIN cell line underwent senescence at PDL 61 while 
the cells with defective p53 function continued to divide for an additional 10 – 20 population doublings. At this point cell death 
equaled cell division, resulting in no net gain of cell number over time. During the approximate 16-week duration of this phase 
the E6-expressing cells died. B. Continuous growth of hTERT-expressing lines. (◆) F1-hTERT+LXIN; (■) F1-hTERT+p53-
A143V; (●) F1-hTERT+p53-H179Q; F1-hTERT+E6.
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% of Cells Exhibiting a G1 Delay
PDL1 F1-
hTERT+LXIN
F1-
hTERT+p53
-A143V
F1-
hTERT+p53
-H179Q
F1-
hTERT+E6
F1-
HIT+LXIN
F1-
HIT+p53-
A143V
F1-
HIT+p53-
H179Q
F1-HIT+E6
30 – 35 100 51 11 0 77 56 22 12
40 – 50 94 44 20 6 95 55 29 0
60 – 65 92 65 5 7 85 54 10 5
75 – 85 80 57 17 1
>1002 97 66 0 0 373 03
Avg.4 93 ± 8 57 ± 9 11 ± 8 3 ± 3 86 ± 9 55 ± 1 20 ± 10 6 ± 6
1. Population Doubling Level
2. PDL of hTERT expressing lines 190 – 210
3. Spontaneous Immortalized Derivative
4. Average ± standard deviation. Average for HIT lines excludes spontaneous immortals.
p53-A143V-expressing cells are able to partially induce p21Waf1Figure 5
p53-A143V-expressing cells are able to partially induce p21Waf1. Western-immuno blot to demonstrating p21Waf1 induction in 
p53-A143V-expressing cells. Log-phase cultures were irradiated with 1.5 Gy. Six hours post-irradiation, the cells were har-
vested and lysed in loading buffer.
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Journal of Carcinogenesis 2005, 4:18 http://www.carcinogenesis.com/content/4/1/18telomerase-negative, p53-H179Q line displayed a more
modest decrement of G2 checkpoint function during aging
with at most 17% of cells evading G2 delay. This repre-
sents the first example in a total of seven independent
analyses of p53-defective human fibroblasts [6,25,37] in
which G2 checkpoint function did not appear to be
severely attenuated in cells at crisis. Interestingly the G2
checkpoint response of the two spontaneously derived
immortal lines (F1-HIT+p53-A143V Immortal and F1-
HIT+p53-H179Q Immortal) was very similar to the
younger (precrisis) parental lines (Figure 7).
In contrast to the aging-associated attenuation of G2
checkpoint function in the telomerase-negative, p53-
defective lines, there was no aging-associated attenuation
of G2 checkpoint function in the telomerase-expressing,
p53-defective lines. Cells at >150 PDL displayed a
response to IR that was nearly equivalent to that seen at
PDL 30 – 40. Thus, the age-related attenuation of G2
checkpoint function in p53-defective lines was prevented
entirely by expression of telomerase.
Cytogenetics of immortal lines
Spontaneously immortalized cells emerged from crisis
after three months in culture (F1-HIT+p53-A143V
Immortal and F1-HIT+p53-H179Q Immortal cell lines).
These two cell lines had DNA damage G1 and G2 check-
point responses that were similar to those seen in their
low-passage parents (Table 2 and Figure 7, respectively).
G-band karyotype analysis of these immortal cell lines
revealed that both were near diploid (45 – 46 chromo-
somes, Table 4). The F1-HIT+p53-H179Q immortal line
exhibited few abnormalities (12% 18q+, 8% 18q-) with
92% of metaphases being 45 XY or 46 XY. The F1-
HIT+p53-A143V immortal line exhibited a somewhat
reduced number of diploid metaphases (72%) and an
Assessment of spindle damage checkpoint function in p53-defective fibroblast linesFigure 6
Assessment of spindle damage checkpoint function in p53-defective fibroblast lines. Endoreduplication was assessed by flow 
cytometric analysis of BrdU-labeled cells 24 and 48 h after addition of colcemid to culture medium.
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Journal of Carcinogenesis 2005, 4:18 http://www.carcinogenesis.com/content/4/1/18increased number of polyploid metaphases (20%) as well
as a small deletion at 4p16 in greater than 50% of met-
aphases. The lines that were transduced with hTERT when
at low PDL were maintained in culture for greater that 175
population doublings. Up to this point, the telomerase
positive, p53-defective lines displayed a normal diploid
karyotype with no marker chromosomal aberrations
(Table 4). However, the F1-hTERT+LXIN control line
exhibited a trisomy for chromosome 8 in 92% of met-
aphases. Interestingly the F1-hTERT+LXIN cell line had a
normal karyotype (25 of 25 metaphases) at an intermedi-
ate PDL of 96.
Discussion
Induced expression of telomerase at the time of inactiva-
tion or attenuation of p53 function fully blocked the chro-
mosomal destabilization that is commonly associated
with defective p53 in human cells. Thus aneuploidization,
polyploidization, and formation of chromosomal aberra-
tions including rings, dicentrics, breaks and exchanges, all
of which develop in human cells with inherited or trans-
duced mutant p53 alleles [38,39] or after transduction of
viral oncoproteins that inactivate p53 [40-42] appear to
be secondary consequences of telomere erosion.
Telomerase-expressing fibroblasts with little or no p53-
dependent G1 checkpoint function exhibited no
detectable numerical or structural chromosomal altera-
Table 3: Quantification of Structural and Numerical Chromosomal Abnormalities in Cell Lines
% of Metaphases Containing:
Cell Line PDL1 # Chromosomes
≤ 44 45 – 47 48 – 85 86 – 99 ≥ 100 Dicentrics + Rings TA2 Breaks Fragments Other3
F1-hTERT+LXIN 32 9 85 0 7 0 0 0 2 0 0
60 2 93 2 3 0 0 2 2 0 0
76 7 93 0 0 0 0 0 0 0 0
F1-hTERT+p53-A143V 31 5 86 3 5 2 0 3 0 0 0
66 0 90 4 4 2 2 0 2 0 0
85 0 96 2 2 0 0 5 4 0 0
F1-hTERT+p53-H179Q 33 10 88 0 2 0 0 0 0 0 0
63 2 87 2 9 0 0 0 2 2 0
84 2 98 0 0 0 0 0 0 0 0
F1-hTERT+E6 30 0 86 4 11 0 0 0 0 2 0
63 2 93 4 2 0 4 0 0 0 0
84 2 94 2 0 0 2 0 2 0 0
F1-HIT+LXIN4 31 10 85 2 2 2 0 0 0 0 0
59 2 97 0 2 0 5 0 0 0 0
F1-HIT+p53-A143V 32 8 89 0 4 0 0 0 4 0 0
65 27 48 10 10 5 53 2 3 5 7
76 44 32 7 11 4 22 2 2 20 0
F1-HIT+p53-H179Q 33 5 91 2 0 0 0 0 0 2 2
63 7 76 2 15 0 37 4 2 7 2
77 23 62 4 9 0 38 2 2 8 2
F1-HIT+E6 32 7 79 9 4 2 5 2 2 2 2
63 33 60 2 5 0 43 0 3 7 0
77 66 24 0 5 0 39 10 0 24 0
1. Population Doubling Level
2. Telomere Associations
3. Exchange Aberrations + Deletions
4. These cells senesced at 60 population doublingsPage 10 of 16
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blings. This finding has implications for the mechanisms
of genetic instability in cancer and its precursors.
In this study eight isogenic cell lines were derived that dif-
fered from each other by one or two alleles. All cell lines
expressing dominant-negative forms of p53 or the
HPV16E6 oncoprotein to interfere with p53 signaling
bypassed the senescence checkpoint. However, expression
of the p53-A143V allele caused only a 50 % attenuation of
DNA damage G1 checkpoint function regardless of
telomerase expression. The partial expression of this
checkpoint response was associated with partial induction
of p21Waf1 protein 6 hr after exposure to 1.5 Gy IR (Figure
3, and Figure 5). This observation is consistent with the
report that the V143A allele of p53 binds to and transacti-
vates p53-responsive promoters [43]. When transduced
by transfection the A143V allele of p53 has been reported
to override the senescence checkpoint and induce severe
chromosomal destabilization as seen here [44].
The continued erosion of telomeres in cells bypassing the
replicative senescence checkpoint results in a cycle of for-
mation of dicentric chromosomes leading to non-disjunc-
tion errors and broken chromosomes that, when repaired,
may result in translocations, deletions, or more dicentrics.
The telomerase-expressing p53 defective cells used in this
study accumulated no structural or numerical abnormali-
ties when grown in culture for greater than 170 popula-
tion doublings. In contrast to other reports, the
telomerase-positive control cell line (F1-hTERT+LXIN)
demonstrated no evidence of chromosomal destabiliza-
tion or morphological changes through approximately
100 PD's [14,45]. However during the next 75 population
doublings this cell line did acquire a trisomy for chromo-
some 8. The trisomy for chromosome 8 seen in the F1-
hTERT+LXIN cells at PDL 175 has also been observed in
this laboratory in another telomerized human fibroblast
line around PDL 200 [46]. Trisomy for chromosome 8 is
commonly found in many hyperproliferative disorders
and is believed to provide a growth advantage to those
DNA damage G2 checkpoint function in aging fibroblastsFigure 7
DNA damage G2 checkpoint function in aging fibroblasts. Log-phase cultures at low and high PDL were treated with 1.5 Gy of 
IR then incubated for 2 h before determination of mitotic index. The percentage of mitotic cells in irradiated cultures was 
divided by the percentage of mitotic cells in sham-treated controls to determine the percent of cells evading G2 delay [25].Page 11 of 16
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could have selected for the cell or cells that underwent
nondisjunction and acquired the extra chromosome,
although population expansion by the F1-hTERT+LXIN
line did not increase after PDL 100 (Figure 4B). Recent
studies demonstrate that the forced expression of telomer-
ase in skin fibroblasts and other cell types enhances cell
proliferation [9]. These effects of telomerase did not
appear to alter cellular responses to IR-induced DNA dam-
age as shown here or UV-induced DNA damage as previ-
ously reported [51].
Chromosomal destabilization associated with telomere
crisis has also been correlated with attenuation and inac-
tivation of DNA damage G2 checkpoint function
[6,25,29]. Because this checkpoint blocks mitosis by cells
with damaged chromatids, it was hypothesized that chro-
mosomally unstable cells with defects in the G2 check-
point would have a growth advantage and accumulate in
Expression constructs used in this studyFigure 8
Expression constructs used in this study. CMV/ie Pro/Enh, Cytomegalovirus immediate early promoter/enhancer sequence; 
VSV-G, vesicular stomatitis virus glycoprotein G; SV40 Pro, simian virus 40 promoter/origin sequence; IRES, internal ribosome 
entry sequence; MuLV LTR, murine leukemia virus long terminal repeat; hTERT, human telomerase catalytic subunit. A) Plas-
mid pCI VSV-G expressing VSV-G used to pseudotype replication-defective retrovirus particles. B) Helper plasmid pCI GPZ 
for packaging replication-defective retrovirus particles. C) pDSWK-8 plasmid vector used to package telomerase cDNA. D) 
pLXSN-E6 plasmid vector for packaging HPV16 E6. E) pLXIN+p53-A143V and pLXIN+p53-H179Q plasmid vectors for packag-
ing dominant-negative p53 alleles.
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Cell Line Chromosome Number1 Karyotype2
F1-hTERT+LXIN (3PDL 173.5) 46, XY (16%) +8 [72%]
47, XY (76%) +8, -Y [8%]
+8, -16
+8, -11
+8, 5q-
F1-hTERT+p53-A143V (PDL 217.6) 46, XY (80%) t(1;4)
12q-
-13
-X
-15
+ marker
F1-hTERT+p53-H179Q (PDL 200.8) 46, XY (84%) +20
12p-
15q-
19q-
-7
+ marker (iso 5p?)
-21
F1-hTERT+E6 (PDL 160.2) 46, XY (80%) -Y
-Y, 11q-
-6, 12p-
-15
+4
9q chromatid break
F1-HIT+p53-A143V Immortal 45, XY (16%) 4p- [24%]
46, XY (56%) 4p-, 4q- [16%]
>90 (20%) two 4p-, two 4q-, dic 13q;13q, four of every chromosome
-Y
6q-
-13, 4p+
-15, -18, 3p-, 2 markers
-15, -18, 3p-
-19, 4p-
4p-, dic 2p;2p
-14, -15, t(5q;14q), t(4p;15q)
-22, 4p-
-20, 10p+
seven 22+
F1-HIT+p53-H179Q Immortal 45, XY (20%) -4, 18q-
46, XY (72%) 4p+, -11, -16, 18q-
18q+ [8%]
16q-
-21, -22, 18q+
-18, 4p+
-15
-17
-18
4q chromatid break
1. Twenty five metaphases analyzed. Number in parenthesis is percentage of metaphases with given number of chromosomes.
2. Karyotype of samples. Number in brackets is percentage of metaphases examined with given karyotype.
3. PDL, population doubling level. PDL of the spontaneously immortalized lines cannot be determined due to the extended period of time the cells 
spent in crisis.Page 13 of 16
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the severe instability of chromosomes at crisis impeded
progression through mitosis, so that upon irradiation
damaged cells complete mitosis at a slower than normal
rate. Yang et al. described a rad9-dependent checkpoint in
S. cerevisiae that responds to the presence of a dicentric
chromosome to delay progression through mitosis [52]. If
human fibroblasts with dicentric chromosomes are also
delayed in their progression through mitosis, this
phenomenon could explain the attenuation of G2 check-
point function seen as p53-defective cells enter crisis. As
the efficacy of G2 checkpoint function is quantified by the
degree of emptying of the mitotic compartment 2 h after
irradiation, a reduced rate of progression through mitosis
to G1 will have the effect of sustaining a higher mitotic
index in control and irradiated cells. This explanation
would view the attenuation of G2 checkpoint function
during telomere crisis as another manifestation of chro-
mosomal instability. The correction of G2 checkpoint
function in the immortal lines that emerged from crisis
with stable chromosomes also supports this explanation.
There are other ways to attenuate DNA damage G2 check-
point function such as inactivation of ATM [53], BRCA1
and 14-3-3ε [54] or overexpression of cyclin B1/Cdk1
kinase [55]. The common attenuation of DNA damage G2
checkpoint function in small cell lung cancer but not
squamous cell carcinoma [54] implies that this pathway
of DNA damage response protects against carcinogenesis
in selected targets.
Human fibroblasts with inherited mutations in p53 or
ectopic expression of HPV16E6 spontaneously immortal-
ize at a low frequency [6,38]. During crisis, prior to
immortalization, these cell lines exhibit both numerical
and structural chromosomal abnormalities. The loss of
chromosomes (Table 3) seen in these lines may be due to
non-disjunction errors or artifacts associated with the
processing of the metaphase preparations. It is not possi-
ble to distinguish between these possibilities. However,
since this was not observed in the telomerized cell lines or
in the non-telomerized cell lines prior to crisis, this phe-
nomenon is likely to be a function of the underlying chro-
mosomal instability. The cell lines, which result from
spontaneous immortalization, have usually activated tel-
omerase expression although in some cases telomeres
appear to be stabilized by an alternative mechanism (ALT)
[56]. These immortal lines are often aneuploid [38]. In
this study, the F1-HIT+p53-A143V and F1-HIT+p53-
H179Q lines yielded immortal derivatives. These immor-
tal lines were both diploid (45 – 46 chromosomes). The
p53-A143V line displayed a marker chromosomal aberra-
tion (4p-) in over half of the metaphases. Deletions in this
region are associated with Wolf-Hirschhorn syndrome
[57]. The p53-H179Q immortal line primarily contained
aberrations in chromosome 18 (both losses and gains).
Chromosome 18 aberrations have been associated with
various malignancies in humans [58,59]. These findings
demonstrating only subtle changes in the karyotype fol-
lowing immortalization are consistent with the previous
observation that aneuploidy is not an inevitable outcome
of in vitro immortalization [60]. Taken together, these
results may reflect the fact that all that is required for con-
tinuous in vitro growth of human fibroblasts is hTERT
expression. Genetic changes that are not cytogenetically
detectable apparently are able to derepress hTERT expres-
sion and induce immortality.
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